This article is more than 5 years old. Information may no longer be current.

Zimmer Biomet announces exclusive distribution agreement with Nextremity Solutions for foot, ankle portfolio

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Zimmer Biomet Holdings Inc. announced an exclusive agreement with Nextremity Solutions Inc. to globally distribute its foot and ankle deformity correction products.

“We are excited to expand the clinical capabilities of our foot and ankle portfolio with Nextremity Solutions’ deformity correction products,” Brad Quick, general manager of Zimmer Biomet Foot and Ankle, said in a release. “The agreement helps advance our commitment to provide customers with the broadest range of cutting-edge technologies and strengthens our position in the $2 billion foot and ankle market.”

According to the release, Nextremity Solutions designs and manufactures procedure-ready, sterile implant systems for foot and ankle pathologies. Zimmer Biomet will now globally distribute these systems. The financial terms of the agreement have not been publically disclosed.

Reference:

http://investor.zimmerbiomet.com/releasedetail.cfm?ReleaseID=994743